Could a pill replace insulin shots for tiny newborns?
NCT ID NCT05687500
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 24 times
Summary
This study tests whether an oral medicine called glibenclamide can safely control high blood sugar in very premature babies (born before 32 weeks, weighing under 1500 grams). The goal is to see if it can replace insulin therapy. The trial involves 35 infants and measures blood sugar control over 72 hours.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRETERM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hopital Necker - Enfants malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.